Related references
Note: Only part of the references are listed.Impaired cell fusion and differentiation in placentae from patients with intrauterine growth restriction correlate with reduced levels of HERV envelope genes
Matthias Ruebner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
The perinatal implications of angiogenic factors
Gordon C. S. Smith et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2009)
Intrauterine growth restriction and adult disease: the role of adipocytokines
Despina D. Briana et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer
J. M. Foidart et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2009)
Angiogene Faktoren und ihre Rolle in der Entstehung und Vorhersage der Präeklampsie
H. Stepan et al.
ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE (2009)
Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors
Yuditiya Purwosunu et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Severe intrauterine growth restriction pregnancies have increased placental endoglin levels - Hypoxic regulation via transforming growth factor-beta 3
Yoav Yinon et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies
Yang Gu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma
Arindel S. R. Maharaj et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age
Tinnakorn Chaiworapongsa et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies
Johanne Holm Toft et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age
Offer Erez et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
Roberto Romero et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
Intrauterine restriction (IUGR)
Giampaolo Mandruzzato et al.
JOURNAL OF PERINATAL MEDICINE (2008)
Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia
A. Jeyabalan et al.
PLACENTA (2008)
Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin
J. Wipff et al.
RHEUMATOLOGY (2008)
Soluble endoglin as a second-trimester marker for preeclampsia
Christopher J. Robinson et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction
Holger Stepan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia
Hisashi Masuyama et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Pre-eclampsia: Clinical manifestations and molecular mechanisms
Suzanne Baumwell et al.
NEPHRON CLINICAL PRACTICE (2007)
Altered gene expression patterns in intrauterine growth restriction: Potential role of hypoxia
Cathal McCarthy et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction
Wenzel Wallner et al.
CLINICAL SCIENCE (2007)
Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule
Friedrich C. Luft
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Fetal growth restriction: Pathogenic mechanisms
Dev Maulik et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2006)
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha et al.
NATURE MEDICINE (2006)
Endovascular trophoblast invasion: Implications for the pathogenesis of intrauterine growth retardation and preeclampsia
P Kaufmann et al.
BIOLOGY OF REPRODUCTION (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction
TM Mayhew et al.
PLACENTA (2003)
Angiogenesis during primate placentation in health and disease
C Wulff et al.
REPRODUCTION (2003)
Intrauterine growth restriction
K Marsál
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2002)
Angiogenic growth factor expression in placenta
SK Smith et al.
SEMINARS IN PERINATOLOGY (2000)
Share Paper
